Health AI Central
Share:
Peer-Reviewed Publication
ACS Med Chem Lett2025;16(7):1197-1199.July 10, 2025Editorial

Exploring Covalent Modulators in Drug Discovery and Chemical Biology.

Ashley Adams1, Lori Ferrins2,3
1Recursion Pharmaceuticals Inc., Salt Lake City, Utah 84101, United States.
2Department of Pharmaceutical Sciences, Northeastern University, Boston Massachusetts 02115, United States.
3Department of Chemistry and Chemical Biology, Northeastern University, Boston Massachusetts 02115, United States.
PubMed PMC DOI PDF

Create a free account to keep reading

Free members get 10 full research views every month across publications, clinical trials, FDA clearances, adverse events, and NIH grants. No credit card required.

Create Free AccountSign In

Want unlimited research access? See Pro plans

Data Accuracy Notice: Research intelligence on Health AI Central is aggregated from public sources (PubMed, ClinicalTrials.gov, FDA, NIH, CMS, and others) and refreshed nightly. Classifications and derived metrics are produced by automated methods described in our Methodology. We recommend verifying critical data points against the primary sources before making decisions.